SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Samani Nilesh J.) "

Sökning: WFRF:(Samani Nilesh J.)

  • Resultat 101-106 av 106
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
101.
  • Kolz, Melanie, et al. (författare)
  • Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations
  • 2009
  • Ingår i: PLoS genetics. - : Public Library of Science (PLoS). - 1553-7404. ; 5:6, s. e1000504-
  • Tidskriftsartikel (refereegranskat)abstract
    • Elevated serum uric acid levels cause gout and are a risk factor for cardiovascular disease and diabetes. To investigate the polygenetic basis of serum uric acid levels, we conducted a meta-analysis of genome-wide association scans from 14 studies totalling 28,141 participants of European descent, resulting in identification of 954 SNPs distributed across nine loci that exceeded the threshold of genome-wide significance, five of which are novel. Overall, the common variants associated with serum uric acid levels fall in the following nine regions: SLC2A9 (p = 5.2×10−201), ABCG2 (p = 3.1×10−26), SLC17A1 (p = 3.0×10−14), SLC22A11 (p = 6.7×10−14), SLC22A12 (p = 2.0×10−9), SLC16A9 (p = 1.1×10−8), GCKR (p = 1.4×10−9), LRRC16A (p = 8.5×10−9), and near PDZK1 (p = 2.7×10−9). Identified variants were analyzed for gender differences. We found that the minor allele for rs734553 in SLC2A9 has greater influence in lowering uric acid levels in women and the minor allele of rs2231142 in ABCG2 elevates uric acid levels more strongly in men compared to women. To further characterize the identified variants, we analyzed their association with a panel of metabolites. rs12356193 within SLC16A9 was associated with DL-carnitine (p = 4.0×10−26) and propionyl-L-carnitine (p = 5.0×10−8) concentrations, which in turn were associated with serum UA levels (p = 1.4×10−57 and p = 8.1×10−54, respectively), forming a triangle between SNP, metabolites, and UA levels. Taken together, these associations highlight additional pathways that are important in the regulation of serum uric acid levels and point toward novel potential targets for pharmacological intervention to prevent or treat hyperuricemia. In addition, these findings strongly support the hypothesis that transport proteins are key in regulating serum uric acid levels.
  •  
102.
  •  
103.
  • Martin-Ruiz, Carmen M, et al. (författare)
  • Reproducibility of telomere length assessment : an international collaborative study
  • 2015
  • Ingår i: International Journal of Epidemiology. - : Oxford University Press. - 0300-5771 .- 1464-3685. ; 44:5, s. 1673-1683
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Telomere length is a putative biomarker of ageing, morbidity and mortality. Its application is hampered by lack of widely applicable reference ranges and uncertainty regarding the present limits of measurement reproducibility within and between laboratories. Methods: We instigated an international collaborative study of telomere length assessment: 10 different laboratories, employing 3 different techniques [Southern blotting, single telomere length analysis (STELA) and real-time quantitative PCR (qPCR)] performed two rounds of fully blinded measurements on 10 human DNA samples per round to enable unbiased assessment of intra- and inter-batch variation between laboratories and techniques. Results: Absolute results from different laboratories differed widely and could thus not be compared directly, but rankings of relative telomere lengths were highly correlated (correlation coefficients of 0.63-0.99). Intra-technique correlations were similar for Southern blotting and qPCR and were stronger than inter-technique ones. However, inter-laboratory coefficients of variation (CVs) averaged about 10% for Southern blotting and STELA and more than 20% for qPCR. This difference was compensated for by a higher dynamic range for the qPCR method as shown by equal variance after z-scoring. Technical variation per laboratory, measured as median of intra- and inter-batch CVs, ranged from 1.4% to 9.5%, with differences between laboratories only marginally significant (P = 0.06). Gel-based and PCR-based techniques were not different in accuracy. Conclusions: Intra- and inter-laboratory technical variation severely limits the usefulness of data pooling and excludes sharing of reference ranges between laboratories. We propose to establish a common set of physical telomere length standards to improve comparability of telomere length estimates between laboratories.
  •  
104.
  •  
105.
  • Styrkarsdottir, Unnur, et al. (författare)
  • Whole-genome sequencing identifies rare genotypes in COMP and CHADL associated with high risk of hip osteoarthritis
  • 2017
  • Ingår i: Nature Genetics. - : Springer Science and Business Media LLC. - 1061-4036 .- 1546-1718. ; 49:5, s. 801-805
  • Tidskriftsartikel (refereegranskat)abstract
    • We performed a genome-wide association study of total hip replacements, based on variants identified through whole-genome sequencing, which included 4,657 Icelandic patients and 207,514 population controls. We discovered two rare signals that strongly associate with osteoarthritis total hip replacement: a missense variant, c.1141G>C (p.Asp369His), in the COMP gene (allelic frequency = 0.026%, P = 4.0 × 10-12, odds ratio (OR) = 16.7) and a frameshift mutation, rs532464664 (p.Val330Glyfs∗106), in the CHADL gene that associates through a recessive mode of inheritance (homozygote frequency = 0.15%, P = 4.5 × 10-18, OR = 7.71). On average, c.1141G>C heterozygotes and individuals homozygous for rs532464664 had their hip replacement operation 13.5 years and 4.9 years earlier than others (P = 0.0020 and P = 0.0026), respectively. We show that the full-length CHADL transcript is expressed in cartilage. Furthermore, the premature stop codon introduced by the CHADL frameshift mutation results in nonsense-mediated decay of the mutant transcripts.
  •  
106.
  • Zhang, Yin, et al. (författare)
  • Endocrine vasculatures are preferable targets of an antitumor ineffective low dose of anti-VEGF therapy
  • 2016
  • Ingår i: Proceedings of the National Academy of Sciences of the United States of America. - : NATL ACAD SCIENCES. - 0027-8424 .- 1091-6490. ; 113:15, s. 4158-4163
  • Tidskriftsartikel (refereegranskat)abstract
    • Anti-VEGF-based antiangiogenic drugs are designed to block tumor angiogenesis for treatment of cancer patients. However, anti-VEGF drugs produce off-tumor target effects on multiple tissues and organs and cause broad adverse effects. Here, we show that vasculatures in endocrine organs were more sensitive to anti-VEGF treatment than tumor vasculatures. In thyroid, adrenal glands, and pancreatic islets, systemic treatment with low doses of an anti-VEGF neutralizing antibody caused marked vascular regression, whereas tumor vessels remained unaffected. Additionally, a low dose of VEGF blockade significantly inhibited the formation of thyroid vascular fenestrae, leaving tumor vascular structures unchanged. Along with vascular structural changes, the low dose of VEGF blockade inhibited vascular perfusion and permeability in thyroid, but not in tumors. Prolonged treatment with the low-dose VEGF blockade caused hypertension and significantly decreased circulating levels of thyroid hormone free-T3 and -T4, leading to functional impairment of thyroid. These findings show that the fenestrated microvasculatures in endocrine organs are more sensitive than tumor vasculatures in response to systemic anti-VEGF drugs. Thus, our data support the notion that clinically nonbeneficial treatments with anti-VEGF drugs could potentially cause adverse effects.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 101-106 av 106
Typ av publikation
tidskriftsartikel (106)
Typ av innehåll
refereegranskat (104)
övrigt vetenskapligt/konstnärligt (2)
Författare/redaktör
Samani, Nilesh J. (103)
Salomaa, Veikko (52)
Nelson, Christopher ... (44)
Deloukas, Panos (42)
Munroe, Patricia B. (42)
van der Harst, Pim (41)
visa fler...
Gieger, Christian (40)
Melander, Olle (38)
Perola, Markus (37)
Uitterlinden, André ... (37)
Wareham, Nicholas J. (36)
van Duijn, Cornelia ... (36)
Peters, Annette (36)
Caulfield, Mark J. (36)
Boerwinkle, Eric (36)
Esko, Tõnu (36)
McCarthy, Mark I (35)
Kathiresan, Sekar (35)
Metspalu, Andres (34)
Loos, Ruth J F (34)
Gudnason, Vilmundur (34)
Luan, Jian'an (33)
Schunkert, Heribert (33)
Erdmann, Jeanette (32)
Farrall, Martin (31)
Watkins, Hugh (31)
Chasman, Daniel I. (30)
Boehnke, Michael (30)
Thorsteinsdottir, Un ... (30)
Stefansson, Kari (30)
Harris, Tamara B (30)
Hayward, Caroline (30)
Hofman, Albert (29)
Elliott, Paul (29)
Laakso, Markku (28)
Thorleifsson, Gudmar (28)
Mangino, Massimo (28)
Asselbergs, Folkert ... (28)
Rudan, Igor (27)
Ridker, Paul M. (27)
Hall, Alistair S. (27)
Willer, Cristen J (27)
Mohlke, Karen L (26)
Rotter, Jerome I. (26)
Lind, Lars (25)
Langenberg, Claudia (25)
Jarvelin, Marjo-Riit ... (25)
Palmer, Colin N. A. (25)
Meitinger, Thomas (25)
Zhao, Jing Hua (25)
visa färre...
Lärosäte
Lunds universitet (57)
Uppsala universitet (40)
Umeå universitet (29)
Karolinska Institutet (24)
Linköpings universitet (9)
Göteborgs universitet (8)
visa fler...
Stockholms universitet (2)
Handelshögskolan i Stockholm (1)
visa färre...
Språk
Engelska (106)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (90)
Naturvetenskap (6)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy